A Study to Compare Neostigmine vs Sugammadex in Length of PACU Stay in Patients Undergoing Sleeve Gastrectomy Surgery

Phase 4

Terminated

Conditions: Postoperative Nausea and Vomiting
Respiratory Conditions Due to Other External Agents

Brief Summary: The investigators will track bariatric patients who received sugammadex versus neostigmine in the post anesthesia care unit until discharge and assess their length of stay and possible nausea / vomiting / hypoxia episodes.

Detailed Description: During their preadmission testing, patients planning to undergo sleeve gastrectomy bariatric surgeries will be consented (by having them sign consent forms) and recruited for the study. A trained individual will track these patients after the surgery in the post anesthesia care unit until discharge and assess their length of stay and possible nausea / vomiting. The exact time the investigators are looking to assess is patient arrival to the post anesthesia care unit until patient ready for discharge when the anesthesiologist writes the anesthesia evaluation. The time the reversal agent is administered during the start of skin closure until patient medically ready to leave the post anesthesia care unit will also be taken into account. Blinded to the treatment group, the trained individual will ask each patient every 15 minutes after arrival to the post anesthesia care unit if they are experiencing nausea or vomiting. As an exploratory measure, the trained individual will assess the patient at these same times (every 15 minutes) and determine their oxygen saturation. The investigators will take all the data from the observations and use statistical means to measure what is significant. A discussion and conclusion will follow. Finally, the principal investigator will submit the study outcomes to an anesthesia journal.

Recruitment & Eligibility

Inclusion Criteria

Exclusion Criteria

Patients having a different type of bariatric surgery including but not limited to duodenal switch, gastric bypass, hand-assisted laparoscopic sleeve gastrectomy
Sleeve gastrectomy's performed by other surgeons than Dr. Sam Wasser.
Pregnancy
Allergic to sugammadex, Zofran or scopolamine
Chronic Obstructive Pulmonary Disease or Asthma that is uncontrolled
American Society of Anesthesiologists Score I, IV, V patients

Arm && Interventions

Group	Intervention	Description
Control Group/Neostigmine	Neostigmine	The control group will be the 63 patients who receive Neostigmine in a dose of 5mg, along with the anti-cholinergic glycopyrrolate 0.6mg.
Study Group/Sugammadex	Sugammadex	63 patients will be given Sugammadex in a dose of 2mg/kg if the train of four twitch count is 2 and 4mg/kg if the twitch response has reached 1-2 post-tetanic counts with no twitch response to train of four.

Primary Outcome Measures

Name	Time	Method
Post Anesthesia Care Unit Length of Stay	Observations will be made during each patient's stay in the post anesthesia care unit (about 120 minutes).	Determine the difference in length of stay in the post anesthesia care unit from patient arrival until ready for post anesthesia care discharge for the American Society of Anesthesiologists Score II and III patients reversed with Sugammadex versus Neostigmine in sleeve gastrectomy surgeries.

Secondary Outcome Measures

Name	Time	Method
Incidence of Postoperative Nausea and Vomiting	Observations will be made during each patient's stay in the post anesthesia care unit (about 120 minutes).	Assess the incidence of Postoperative Nausea and Vomiting in the American Society of Anesthesiologists Score II and III patients reversed with Sugammadex versus Neostigmine at arrival to the post anesthesia care unit and every 15 minutes while in the post anesthesia care unit, with the prediction that there will be a lower incidence of Postoperative Nausea and Vomiting in the Sugammadex group.
Incidence of Respiratory Complications	Observations will be made during each patient's stay in the post anesthesia care unit (about 120 minutes).	Assess the incidence of respiratory complications postoperatively specifically looking at oxygen saturation at patient arrival to the post anesthesia care unit and every 15 minutes after arrival to the post anesthesia care unit and any intervention necessary.